WCN26-390 A PHASE-4, 52-WEEK, SINGLE ARM, POST-MARKETING SURVEILLANCE TO EVALUATE SAFETY OF DESIDUSTAT FOR TREATMENT OF ANEMIA IN SUBJECTS WITH CHRONIC KIDNEY DISEASE

Read full text Summarise with VIRAT
Authors: Prakash Khetan, Hardik Kirit Shah, Umesh B. Khanna, Rana Gopal Singh, Siddharth Mavani, Deven Parmar, Kevinkumar Kansagra, Suchi Shah, Tejaskumar Mehta, Syed Haque
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Pharmacovigilance and Adverse Drug Reactions Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104189–104189
Publication date
25 March 2026
Language
EN